USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Microanalytic Research Inc
Address:
23461 Ridge Rte Unit H
Laguna Hills, CA 92653
Phone:
N/A
URL:
N/A
EIN:
N/A
DUNS:
N/A
Number of Employees:
8
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,606.00 3
SBIR Phase II $439,471.00 1

Award List:

DEVELOPMENT OF SIMPLE AND RELIABLE DIAGNOSTIC TESTS FOR CYST

Award Year / Program / Phase:
1985 / SBIR / Phase I
Award Amount:
$49,606.00
Agency:
HHS
Principal Investigator:
Jeffrey C. Travis , Principal Investigator
Abstract:
N/a

DEVELOPMENT OF SIMPLE AND RELIABLE DIAGNOSTIC TESTS FOR CYST

Award Year / Program / Phase:
1986 / SBIR / Phase II
Award Amount:
$439,471.00
Agency:
HHS
Principal Investigator:
Jeffrey C. Travis , Principal Investigator
Abstract:
The most common lethal autosomal recessive genetic disease among caucasians is cystic fibrosis (cf), which afflicts one in 2000 newborns. the most accepted diagnostic test for cf is the quantitative sweat test, which, though accurate when performed correctly, is unreliable in its routine clinical… More

SPECIFIC ASSAYS FOR FENTANYL DERIVATIVES AND METABOLITES

Award Year / Program / Phase:
1987 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Peter b dewhurst phd
Abstract:
The long-term objective of this project is the development of a rapid quantitative assay for fentanyl and a qualitativeassay (screen) for fentanyl and other narcotics of the 4-anilinopiperidine series. the assay will be developed with the goal of measuring the drugs in whole blood spotted on filter… More

EARLY IMMUNE RESPONSE-DETECTION BY RAPID NEOPTERIN ASSAY

Award Year / Program / Phase:
1988 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Abstract:
The long-term objective of this research is development, optimization and commercial sale of an innovative, rapid andcost-effective screening method for neopterin and its hydrogenated congeners in body fluids. ultimately, in phaseii this will take the form of a visible cut-off eia screen performed… More